Correlation Between Acrivon Therapeutics, and Protagenic Therapeutics
Can any of the company-specific risk be diversified away by investing in both Acrivon Therapeutics, and Protagenic Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acrivon Therapeutics, and Protagenic Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acrivon Therapeutics, Common and Protagenic Therapeutics, you can compare the effects of market volatilities on Acrivon Therapeutics, and Protagenic Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acrivon Therapeutics, with a short position of Protagenic Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acrivon Therapeutics, and Protagenic Therapeutics.
Diversification Opportunities for Acrivon Therapeutics, and Protagenic Therapeutics
0.45 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Acrivon and Protagenic is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Acrivon Therapeutics, Common and Protagenic Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protagenic Therapeutics and Acrivon Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acrivon Therapeutics, Common are associated (or correlated) with Protagenic Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protagenic Therapeutics has no effect on the direction of Acrivon Therapeutics, i.e., Acrivon Therapeutics, and Protagenic Therapeutics go up and down completely randomly.
Pair Corralation between Acrivon Therapeutics, and Protagenic Therapeutics
Given the investment horizon of 90 days Acrivon Therapeutics, Common is expected to generate 0.44 times more return on investment than Protagenic Therapeutics. However, Acrivon Therapeutics, Common is 2.27 times less risky than Protagenic Therapeutics. It trades about -0.03 of its potential returns per unit of risk. Protagenic Therapeutics is currently generating about -0.06 per unit of risk. If you would invest 785.00 in Acrivon Therapeutics, Common on September 4, 2024 and sell it today you would lose (41.00) from holding Acrivon Therapeutics, Common or give up 5.22% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Acrivon Therapeutics, Common vs. Protagenic Therapeutics
Performance |
| Timeline |
| Acrivon Therapeutics, |
| Protagenic Therapeutics |
Acrivon Therapeutics, and Protagenic Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Acrivon Therapeutics, and Protagenic Therapeutics
The main advantage of trading using opposite Acrivon Therapeutics, and Protagenic Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acrivon Therapeutics, position performs unexpectedly, Protagenic Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protagenic Therapeutics will offset losses from the drop in Protagenic Therapeutics' long position.| Acrivon Therapeutics, vs. Aerovate Therapeutics | Acrivon Therapeutics, vs. Adagene | Acrivon Therapeutics, vs. Rezolute | Acrivon Therapeutics, vs. AN2 Therapeutics |
| Protagenic Therapeutics vs. Sino Biopharmaceutical Ltd | Protagenic Therapeutics vs. Eledon Pharmaceuticals | Protagenic Therapeutics vs. Rezolute | Protagenic Therapeutics vs. XOMA Corporation |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |